FDA Commissioner Robert M. Califf has said that advances in gene knowledge could lead to gene-editing for the cure of diseases. The relatively recent advances in data sharing and genomic study will allow for precision medical therapies, Califf said in his keynote address to the “Improving Clinical Research in the Age of Precision Medicine” symposium on 14-15 September. In a press release issued by the American Society for Cell Biology, Dr. David Sinclair, Director of the Center for Genome Sciences at Harvard Medical School, said: “The advent of genome sequencing technology is changing our understanding of
FDA Commissioner Robert M. Califf has said that advances in gene knowledge could lead to gene-editing for the cure of diseases. The relatively recent advances in data sharing and genomic study will allow for precision medical therapies, Califf said in his keynote address to the “Improving Clinical Research in the Age of Precision Medicine” symposium on 14-15 September. The ability of gene editing to remove or replace genes that cause diseases could be used in the near future for genetic-related illnesses, such as sickle cell disease, which has been treated successfully in mice using a genetically-engineered virus.